SC 13G
1
MRVI13G2023.txt
THE UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(AMENDMENT NO. 1)*
Maravai Lifesciences Holdings Inc
(Name of Issuer)
CLASS A COMMON STOCK, PAR VALUE $0.01 PER SHARE
(Title of Class of Securities)
56600D107
(CUSIP Number)
December 31, 2023
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[ X ] Rule 13d-1(c)
[ ] Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section
of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
CUSIP No. 56600D107
1.
NAMES OF REPORTING PERSONS
12 West Capital Management LP
45-3076594
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
3.
SEC USE ONLY
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware, United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5.
SOLE VOTING POWER: 11,602,988**
6.
SHARED VOTING POWER: 0**
7.
SOLE DISPOSITIVE POWER: 11,602,988**
8.
SHARED DISPOSITIVE POWER: 0**
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
11,602,988**
10.
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ]
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): 8.78%
12.
TYPE OF REPORTING PERSON (see instructions): IA
**12 West Capital Management LP (12 West Management) serves as the investment
manager to 12 West Capital Fund LP, a Delaware limited partnership (12 West
Onshore Fund) and 12 West Capital Offshore Fund LP, a Cayman Islands exempted
limited partnership (12 West Offshore Fund) and possesses the sole power to
vote and the sole power to direct the disposition of all securities of Maravai
Lifesciences Holdings Inc (the Company) held by 12 West Onshore Fund and 12
West Offshore Fund. Joel Ramin, as the sole member of 12 West Capital
Management, LLC, the general partner of 12 West Management, possesses the
voting and dispositive power with respect to all securities beneficially owned
by 12 West Management.
As of December 31, 2023, The Company had 132,188,600 Class A ordinary shares,
par value $0.00003 per share (the Ordinary Shares) outstanding. As of
December 31, 2023, 12 West Onshore Fund held 7,301,526 shares of the Company
and 12 West Offshore Fund held 4,301,462 shares of the Company. As a result of
the foregoing, for purposes of Reg. Section 240.13d-3, 12 West Management is
deemed to beneficially own the 11,602,988 shares of the Company, representing
8.78% of the Companys Ordinary Shares deemed issued and outstanding as of
December 31, 2023.
Item 1.
(a)
Name of Issuer
Maravai Lifesciences Holdings Inc
(b)
Address of Issuers Principal Executive Offices
10770 Wateridge Circle
Suite 200
San Diego, California, 92121
Item 2.
(a)
Name of Person Filing
12 West Capital Management LP
(b)
Address of Principal Business Office, or, If None, Residence:
475 Tenth Avenue, 14th Floor
New York, New York 10018
(c)
Citizenship:
12 West Capital Management LP is a Delaware limited partnership
(d)
Title of Class of Securities
Class A Common Stock, par value $0.01 per share
(e)
CUSIP Number
56600D107
Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b)
or (c), check whether the person filing is a:
Not applicable
Item 4. Ownership.
(a) Amount beneficially owned:
11,602,988**
(b) Percent of class: 8.78%
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote: 11,602,988**
(ii) Shared power to vote or to direct the vote: 0**
(iii) Sole power to dispose or to direct the disposition of: 11,602,988**
(iv) Shared power to dispose or to direct the disposition of: 0**
__________________
**12 West Capital Management LP (12 West Management) serves as the investment
manager to 12 West Capital Fund LP, a Delaware limited partnership
(12 West Onshore Fund) and 12 West Capital Offshore Fund LP, a Cayman Islands
exempted limited partnership (12 West Offshore Fund) and possesses the sole
power to vote and the sole power to direct the disposition of all securities
of Maravai Lifesciences Holdings Inc (the Company) held by 12 West Onshore
Fund and 12 West Offshore Fund. Joel Ramin, as the sole member of 12 West
Capital Management, LLC, the general partner of 12 West Management, possesses
the voting and dispositive power with respect to all securities beneficially
owned by 12 West Management.
As of December 31, 2023, The Company had 132,188,600 Class A ordinary shares,
par value $0.01 per share (the Ordinary Shares) outstanding. As of December
31, 2023, 12 West Onshore Fund held 7,301,526 shares of the Company and 12 West
Offshore Fund held 4,301,462 shares of the Company. As a result of the
foregoing, for purposes of Reg. Section 240.13d-3, 12 West Management is deemed
to beneficially own the 11,602,988 shares of the Company, representing 8.78%
of the Companys Ordinary Shares deemed issued and outstanding as of December
31, 2023.
Item 5. Ownership of Five Percent or Less of a Class.
Not Applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Not Applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company.
Not Applicable.
Item 8. Identification and Classification of Members of the Group.
Not Applicable.
Item 9. Notice of Dissolution of Group.
Not Applicable.
Item 10. Certification.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are not held
for the purpose of or with the effect of changing or influencing the control of
the issuer of the securities and were not acquired and are not held in
connection with or as a participant in any transaction having that purpose or
effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Dated: December 31, 2023
12 WEST CAPITAL MANAGEMENT LP
By: 12 West Capital Management, LLC, its General Partner
By: /s/ Joel Ramin______________
Joel Ramin, its Sole Member
